IMMP
Price
$1.63
Change
-$0.05 (-2.98%)
Updated
Apr 25 closing price
Capitalization
231.59M
30 days until earnings call
OXBDF
Price
$3.95
Change
-$0.16 (-3.89%)
Updated
Apr 22 closing price
Capitalization
421.06M
Ad is loading...

IMMP vs OXBDF

Header iconIMMP vs OXBDF Comparison
Open Charts IMMP vs OXBDFBanner chart's image
Immutep
Price$1.63
Change-$0.05 (-2.98%)
Volume$60.69K
Capitalization231.59M
Oxford Biomedica
Price$3.95
Change-$0.16 (-3.89%)
Volume$150K
Capitalization421.06M
IMMP vs OXBDF Comparison Chart
Loading...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMP vs. OXBDF commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMP is a StrongBuy and OXBDF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (IMMP: $1.63 vs. OXBDF: $3.95)
Brand notoriety: IMMP and OXBDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMP: 79% vs. OXBDF: 993%
Market capitalization -- IMMP: $231.59M vs. OXBDF: $421.06M
IMMP [@Biotechnology] is valued at $231.59M. OXBDF’s [@Biotechnology] market capitalization is $421.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMP’s FA Score shows that 0 FA rating(s) are green whileOXBDF’s FA Score has 0 green FA rating(s).

  • IMMP’s FA Score: 0 green, 5 red.
  • OXBDF’s FA Score: 0 green, 5 red.
According to our system of comparison, OXBDF is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMP’s TA Score shows that 4 TA indicator(s) are bullish.

  • IMMP’s TA Score: 4 bullish, 4 bearish.

Price Growth

IMMP (@Biotechnology) experienced а +5.84% price change this week, while OXBDF (@Biotechnology) price change was -4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

IMMP is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($421M) has a higher market cap than IMMP($232M). IMMP YTD gains are higher at: -24.885 vs. OXBDF (-26.784).
IMMPOXBDFIMMP / OXBDF
Capitalization232M421M55%
EBITDA-43.83MN/A-
Gain YTD-24.885-26.78493%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash159MN/A-
Total Debt1.69MN/A-
FUNDAMENTALS RATINGS
IMMP vs OXBDF: Fundamental Ratings
IMMP
OXBDF
OUTLOOK RATING
1..100
250
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9392
PRICE GROWTH RATING
1..100
8158
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMMP's Valuation (50) in the Biotechnology industry is in the same range as OXBDF (50) in the null industry. This means that IMMP’s stock grew similarly to OXBDF’s over the last 12 months.

IMMP's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as OXBDF (100) in the null industry. This means that IMMP’s stock grew similarly to OXBDF’s over the last 12 months.

OXBDF's SMR Rating (92) in the null industry is in the same range as IMMP (93) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to IMMP’s over the last 12 months.

OXBDF's Price Growth Rating (58) in the null industry is in the same range as IMMP (81) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to IMMP’s over the last 12 months.

OXBDF's P/E Growth Rating (98) in the null industry is in the same range as IMMP (100) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMMP
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 22 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRDO43.681.29
+3.04%
Credo Technology Group Holding Ltd
FTCI3.180.05
+1.60%
FTC Solar
EE26.53-0.01
-0.04%
Excelerate Energy
HURN134.14-0.34
-0.25%
Huron Consulting Group
TMO424.24-2.42
-0.57%
Thermo Fisher Scientific

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
-2.98%
PRRUF - IMMP
43%
Loosely correlated
N/A
CALC - IMMP
39%
Loosely correlated
-1.64%
XFOR - IMMP
37%
Loosely correlated
+1.50%
ARCT - IMMP
31%
Poorly correlated
+0.16%
AXON - IMMP
31%
Poorly correlated
+2.22%
More

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and IMMP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and IMMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
IMMP - OXBDF
23%
Poorly correlated
-2.98%
BPMC - OXBDF
21%
Poorly correlated
+1.82%
BDTX - OXBDF
21%
Poorly correlated
-1.24%
ATNM - OXBDF
21%
Poorly correlated
+3.15%
UBX - OXBDF
20%
Poorly correlated
-0.68%
More